Trials / Completed
CompletedNCT04773834
Evaluation of an Automated Physician-Directed Messaging on Patient Engagement in the Digital Diabetes Prevention Program
A Randomized Control Trial to Study the Effects of Automated Physician Directed Messaging on Patient Engagement in a Digital Diabetes Prevention Program
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 551 (actual)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
This study aims to understand the effects of automated physician directed messaging on patient engagement in the digital diabetes prevention program (dDPP). The messages are tailored to patient engagement levels based on established engagement thresholds, which are based on the patient's use of the dDPP application. The system is designed to minimize work for providers by sending automated targeted messages to patients to potentially increase engagement, prevent onset of diabetes and improve clinical outcomes. The patients in the study are automatically nudged using a combination of text messaging and MyChart messaging.
Detailed description
Using a mixed-methods design, this study will be completed in three phases. For Phase 3, we aim to conduct a randomized control trial with 400 patients with pre-diabetic, all of whom will be using the dDPP application. Half of enrolled patients will be randomized to the intervention group and receive automated targeted messaging.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Digital diabetes prevention program (dDPP) | The digital diabetes prevention program is through the Noom app, and the three devices (Fitbit physical activity tracker, Fitbit weight scale, and self-check hemoglobin a1c kit). This is a one year diabetes prevention program where participants will be expected to participate in 5 to 7 interviews over a 18 month period. |
| OTHER | Adapted dDPP-EHR tool | This is a product of Phase 1 and 2 of this study where participants will receive detailed text messaging regarding their engagement levels in Noom app. |
Timeline
- Start date
- 2021-02-01
- Primary completion
- 2025-01-15
- Completion
- 2025-06-01
- First posted
- 2021-02-26
- Last updated
- 2026-03-03
- Results posted
- 2026-01-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04773834. Inclusion in this directory is not an endorsement.